Based on the key measurements obtained from Calumet Specialty's financial statements, Calumet Specialty Products is doing better financially today then in previous quarter. It has a moderate likelihood of reporting better financial numbers in January. At this time, Calumet Specialty's Deferred Long Term Liabilities is comparatively stable compared to the past year. Key indicators impacting Calumet Specialty's financial strength include:
Investors should never underestimate Calumet Specialty's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Calumet Specialty's cash flow, debt, and profitability to make informed and accurate decisions about investing in Calumet Specialty Products.
Net Income
50.51 Million
Calumet
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Free Cash Flow
Other Cashflows From Financing Activities
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change In Working Capital
Begin Period Cash Flow
Depreciation
Change To Liabilities
Dividends Paid
Change To Account Receivables
Sale Purchase Of Stock
Change To Netincome
Change Receivables
Net Borrowings
Stock Based Compensation
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Investments
Change To Operating Activities
Total Assets
Total Stockholder Equity
Property Plant And Equipment Net
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Other Current Liab
Total Current Liabilities
Accounts Payable
Other Liab
Cash
Long Term Debt
Inventory
Other Current Assets
Intangible Assets
Property Plant Equipment
Short Long Term Debt Total
Current Deferred Revenue
Net Debt
Cash And Short Term Investments
Net Receivables
Non Current Liabilities Total
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Good Will
Net Tangible Assets
Retained Earnings
Short Term Investments
Long Term Debt Total
Deferred Long Term Liab
Non Current Liabilities Other
Common Stock
Long Term Investments
Short Long Term Debt
Net Invested Capital
Net Working Capital
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Net Income Applicable To Common Shares
Selling And Marketing Expenses
Preferred Stock And Other Adjustments
Net Income From Continuing Ops
Non Operating Income Net Other
Tax Provision
Discontinued Operations
Non Recurring
Minority Interest
Interest Income
Extraordinary Items
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Calumet Specialty Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Calumet Specialty's financial statements are interrelated, with each one affecting the others. For example, an increase in Calumet Specialty's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Calumet Specialty's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Calumet Specialty Products. Check Calumet Specialty's Beneish M Score to see the likelihood of Calumet Specialty's management manipulating its earnings.
Calumet Specialty Stock Summary
Calumet Specialty competes with Battalion Oil, Granite Ridge, GeoPark, Crescent Energy, and PrimeEnergy. Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. The company was founded in 1916 and is headquartered in Indianapolis, Indiana. Calumet Specialty operates under Oil Gas EP classification in the United States and is traded on NASDAQ Exchange. It employs 1450 people.
The reason investors look at the income statement is to determine what Calumet Specialty's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Calumet Specialty's current stock value. Our valuation model uses many indicators to compare Calumet Specialty value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Calumet Specialty competition to find correlations between indicators driving Calumet Specialty's intrinsic value. More Info.
Calumet Specialty Products is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Calumet Specialty's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Calumet Specialty by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Calumet Specialty Systematic Risk
Calumet Specialty's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Calumet Specialty volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Calumet Specialty correlated with the market. If Beta is less than 0 Calumet Specialty generally moves in the opposite direction as compared to the market. If Calumet Specialty Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Calumet Specialty is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Calumet Specialty is generally in the same direction as the market. If Beta > 1 Calumet Specialty moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Calumet Specialty Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Calumet Specialty's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Calumet Specialty growth as a starting point in their analysis.
Calumet Specialty December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Calumet Specialty help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Calumet Specialty Products. We use our internally-developed statistical techniques to arrive at the intrinsic value of Calumet Specialty Products based on widely used predictive technical indicators. In general, we focus on analyzing Calumet Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Calumet Specialty's daily price indicators and compare them against related drivers.
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.